In this issue:
Disseminate recurrent folliculitis and HS are more prevalent in patients with Down syndrome
High burden of comorbidities in patients with HS
Increased risk of cardiovascular comorbidities in HS
HS and polycystic ovarian syndrome
Sexual dysfunction in patients with HS
Ramadan fasting shows potential for disease control in HS
Intralesional corticosteroid injection for HS lesions
Ustekinumab shows efficacy in HS
Guselkumab in the treatment of concomitant HS, psoriasis and Crohn’s disease
Please login below to download this issue (PDF)